ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NHS saving £300m with Humira biosimilar deal
November 30, 2018The NHS is to save £300 million after striking deals with several manufacturers of low cost biosimilars of AbbVie’s Humira inflammatory diseases drug..... -
Mylan, Fujifilm score EU thumbs-up for Humira biosimilar, putting more pressure on AbbVie
September 21, 2018AbbVie and its investors have been fretting over the potential impact of biosimilar competition to Humira—the world’s top-selling drug, with more than $18 billion a year in sales—and now they have another contender to worry about. -
Boehringer’s Humira biosimilar wins US green light
August 31, 2017US regulators have approved Boehringer Ingelheim’s Cyltezo, a biosimilar to AbbVie’s Humira, in a pre-filled syringe for the treatment of multiple chronic inflammatory diseases
Pharma Sources Insight January 2025
